Sanofi and Biovac partner to produce polio vaccines in Africa

Sanofi and Biovac have announced a partnership to establish the first African-based manufacturing capabilities for inactivated polio vaccines (IPV), marking …

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex (fulvestrant) in the European Union (EU) for the treatment …

Will WHO’s new guidance spur hepatitis B immunisation?

Despite vaccine developments signalling advancements in the diagnosis, prevention and treatment of hepatitis B, the World Health Organization’s (WHO) 2024 …

iOnctura raises nearly $86m in Series B to fund Phase II cancer trials

Swiss biopharma iOnctura has raised €80m ($85.8m) in Series B financing to fund the Phase II clinical trials for its …

MHRA disallows epilepsy drug topiramate use for pregnant patients  

The UK Medicines and Healthcare products Regulatory Agency (MHRA) is introducing new safety measures for topiramate after a study has …